greeksoup/ stock research
Stock research / United States / BBNX / Documents

Beta Bionics, Inc. documents

Beta Bionics (BBNX) annual report: the 10-K filed 24 February 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 10 April 2026; latest 10-Q filed 27 October 2026 for the quarter ended 30 September 2026. Each links to the document on EDGAR, with 5 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
27 October 2026Results press release, exhibit 99 to the 8-K filed 27 October 2026The releaseEDGAR folder
29 July 2026Results press release, exhibit 99 to the 8-K filed 29 July 2026The releaseEDGAR folder
21 April 2026Results press release, exhibit 99 to the 8-K filed 21 April 2026The releaseEDGAR folder
17 February 2026Results press release, exhibit 99 to the 8-K filed 17 February 2026The releaseEDGAR folder
8 January 2026Results press release, exhibit 99 to the 8-K filed 8 January 2026The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
24 February 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
27 October 202610-Q, period ended 30 September 2026The documentEDGAR folder
29 July 202610-Q, period ended 30 June 2026The documentEDGAR folder
21 April 202610-Q, period ended 31 March 2026The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
10 April 2026DEF 14A, period ended 21 May 2026The documentEDGAR folder

Annual report to shareholders

FiledDocumentOpenWhere
10 April 2026ARS, period ended 31 December 2025The documentEDGAR folder